ReviewMethods in molecular biology (Clifton, N.J.)2026
Human Stem Cell-Based Embryo Model Research: Ethics and Regulations.
Review in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- What counts as an embryo? : The regulatory status of stem cell-based embryo models in Asia.EMBO reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given rapid advances in the life sciences, stem cell-based embryo models (SCBEMs) call for careful ethical and regulatory consideration. As with similar research related to human embryos and reproduction, SCBEMs raise important normative questions. In this chapter, we survey these questions, outline possible answers, and discuss their implications for global regulatory development. We also map major ethical issues related to SCBEM research, identify areas in need of further debate, and examine the governance frameworks required for responsible progress. We conclude with recommendations to guide SCBEM research so that it advances scientific innovation while protecting the public interest. In particular, we highlight the importance of careful planning, transparent communication, inclusive dialogue, robust governance, and ongoing empirical inquiry. Taken together, these measures can help ensure that SCBEM research proceeds responsibly, remains ethically sound, and earns public trust.
Indexed as
Identifiers
41042296What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.